Возможности мониторинга эффективности оперативного лечения хронического синовита коленного сустава при ревматоидном артрите

1. <div><p>Насонов Е.Л. Перспективы лабораторной диагностики хронических воспалительных заболеваний и аутоиммунных болезней человека. Рос мед вести 2001;3:20-6.</p><p>Rose N.R. Autoimmune disease: tracing the shared threads. Hosp Pract 1997;32:32-47.</p><p>Boers M., Brooks P., Simon L.S. et al. OMERACT: An international initiative to improve outcome measurement in rheumatology. Clin Exp Rheumatol 2005;23-39:10-3.</p><p>Насонов Е.Л., Насонова В.А. Ревматология. Национальное руководство. М., 2008;290-332.</p><p>Насонов Е.Л., Чичасова Н.В., Баранов А.А. и др. Клиническое значение С-реактивного белка при ревматоидном артрите. Клин мед 1997;7:26-30.</p><p>Harris E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. New Engl J Med 1990;322:1277-89.</p><p>Веникова М.С. Морфологические критерии синовита при ревматоидном артрите в сопоставлении с синовитами при системной красной волчанке и системной склеродермии. Ревматология 1985;4:33-4.</p><p>Павлова В.Н., Копьева Л.И., Слуцкий Л.И., Павлов Г.Г. Хрящ. М., 1983;270 с.</p><p>Fujii J., Shingu M., Nobunaga M. Monocyte activation in early onset rheumatoid arthritis. Ann Rheum Dis 1990;7:497-503.</p><p>Harada T., Ugal K., Hirohata K. Interaction of macrophages with rheumatoid articular cartilage. Kobe J Med Sci 1989;35(8):201-16.</p><p>Маянский А.Н., Маянский Д.Н. Очерки о нейтрофиле и макрофаге. Новосибирск, 1989;245-9.</p><p>Шехтер А.Б., Чичасова Н.В., Крель А.А. Эволюция морфологических проявлений синовита у больных с начальной стадией ревматоидного артрита при различных вариантах его дальнейшего течения. Ревматология 1988;2:3-16.</p><p>Fassbender H.G., Simmling-Annefeld M., Stofft E. Transformation der Synovial Zellen bei rheumatoider Arthritis. Verh Dtsch Ges Pathol 1980;64:193-212.</p><p>Fassbender H.G. Neue morphologische Aspekte der Pathomechanismen bei rheumatoider Arthritis. Rheumamedizin 1983;5(4):996-1101.</p><p>Bromley M., Woolley D.E. Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthr Rheum 1984;27:857-63.</p><p>Riedel U., Geiller G. Immunhistochemische Untersuchungen an der Synovialmemran bei Rheumatoid Arthritis und Osteoarthrose zur Quantifizierung Lysozym- und Alpha-1-Antitrypsin-positiver mononuklearer Zellen. Z Rheumatol 1989;48(6):301-6.</p><p>Shiozawa S., Shiozawa K., Fujita T. Morphological observations in the early phase of the cartilage-pannus junction. Light and elec tron microscopic studies of active cellular pan-nus. Arthr Rheum 1983;26:472-8.</p><p>Fujikawa K., Kawakami A., Tamai M. et al. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion. J Rheumatol 2009;36(6):1126-9.</p><p>Young-Min S., Cawston T., Marshal N. et al. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. Arthr Rheum 2007;56(10):3236-47.</p><p>Hashimoto J., Garnero P., van der Heijde D. et al. A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs. Mod Rheumatol 2009;19(3):273-82.</p><p>Heinegard D., Saxne T. Molecular markers of processing in cartilage in joint disease. Br J Rheumatol 1991;30:21-4.</p><p>Lindqvist E., Eberhardt K., Bendtzen K. et al. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201.</p><p>Roux-Lombard P., Eberhardt K., Saxne T. et al. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study. Rheumatology 2001;40:544-51.</p><p>Mullan R.H., Matthews C., Bresnihan B. et al Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy. Arthr Rheum 2007;56(9):2919-28.</p><p>Cibere J., Zhang H., Garnero P. et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthr Rheum 2009;60(5):1372-80.</p><p>Marotte H., Gineyts E., Miossec P. et al Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis. Ann Rheum Dis 2009;68(7):1197-200.</p><p>Gabay C., Kushner I. Acute/phase proteins and other systemic responses to inflammation. Engl J Med 1999;340:448-54.</p><p>Насонов Е.Л., Чичасова Н.В., Баранов А.А. Клиническое значение С-реактивного белка при ревматоидном артрите. Клин мед 1999;7:26-30.</p><p>Насонов Е.Л. Маркеры воспаления и атеросклероз: значение С-реактивного белка. Кардиология1999;2:81-5.</p><p>Spector T.D., Hart D.J., Nandra D. et al. Low-level increases in</p><p>Науч-практич ревматол 2012; 50(1): 72-75</p><p>Р е в м е serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthr Rheum 1997;40:723-7.</p><p>Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Reum 1988;17:123-9.</p><p>Lohmander L.S., Saxne T., Heinegard D.K. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after injury and in osteoarthritis. Ann Rheum Dis 1994;53:8-13.</p><p>Kong S.Y., Stabler T.V., Criscione L.G. et al. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthr Rheum 2006;54(8):2496-504.</p><p>Foslind K., Ebarhardt K., Jonsson A., Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Rheumatology 1992;31:593-8.</p><p>Skoumal M., Kolarz G., Klingler A. Serum levels of cartilage oligomeric matrix protein. Scand J Rheumatol 2003;32:156-61.</p><p>Fex E., Eberhardt K., Saxne T. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis:relationship to development of joint destruction in hands and feet. Br J Rheumatol 1997;36:1161-5</p><p>De Young Z., Munneke M., Vilim V. et al. Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis-data from the RAPIT study. Rheumatology 2008;47:868-71.</p><p>Turesson C., Bergstrom U., Jacobsson L.T.H. et al. Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann Rheum Dis 2011;70:520-2.</p><p>Hetland M., Stengaard-Pedersen K., Junker P. et al. Radiographic progression and remission rates in early rheumatoid arthritis-MRI bone oedema and anti-CCP predicted radiographic progression in 5-year extension of double-blined randomized CIMESTRA trial. Ann Rheum Dis 2010;69:1789-95.</p><p>McCachren S.S. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthr Rheum 1991;34:1085-93.</p><p>Kubacki J., Kokosz M., Grygorowicz M. et al. The value of synovectomy of the knee in the treatment of rheumatoid arthritis. Ortop Traumatol Rehabil 2006;8(1):99-105.</p><p>Murgo A., Paresce E., Fantini F. Arthroscopic synovectomy in chronic inflammatory rheumatism: clinical and functional aspects. Reumatismo 2003;55(1):39-44.</p></div><br />